Stock listing
Munich:6NQ SYNTHAVERSE Spolka Akcyjna Aktie
German listing (Munich) of SYNTHAVERSE Spolka Akcyjna · home listing GPW:SVE
Follow SYNTHAVERSE Spolka Akcyjna into a list and get an email when it puts out news.
Home listing price · GPW:SVE
2.60 PLN -0.07 (-2.6%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, GPW:SVE
- Day range
- 2.58 – 2.67 PLNNov 20, 2026
- Volume
- 29,136 sharesNov 20, 2026
- Market cap
- 197.7M PLNAt the close on Nov 20, 2026 · price × 76.02M shares outstanding
- 52-week range
- 2.45 – 4.25 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 122,621 PLNMedian day 32,563 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| GPW:SVE · Home | 2.60 PLN | -0.07 (-2.6%) | 29,136 | 2.65 | 2.665 | 2.58 | 2.67 | Close on Nov 20, 2026 |
| Frankfurt:6NQ | €0.579 EUR | -0.013 (-2.2%) | — | €0.585 | €0.585 | €0.579 | €0.592 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:SVE · PLN, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 2.60 | -0.07 | -2.6% | 2.65 | 2.665 | 2.58 | 29,136 | |
| 2.67 | -0.01 | -0.4% | 2.69 | 2.765 | 2.67 | 43,554 | |
| 2.68 | -0.16 | -5.6% | 2.85 | 2.87 | 2.68 | 116,017 | |
| 2.84 | +0.19 | +7.2% | 2.72 | 2.885 | 2.72 | 255,122 | |
| 2.65 | -0.05 | -1.9% | 2.70 | 2.70 | 2.62 | 43,343 | |
| 2.70 | +0.13 | +5.1% | 2.57 | 2.795 | 2.55 | 106,838 | |
| 2.57 | -0.01 | -0.4% | 2.57 | 2.58 | 2.45 | 47,332 | |
| 2.58 | -0.01 | -0.4% | 2.56 | 2.59 | 2.56 | 10,571 | |
| 2.59 | +0.01 | +0.4% | 2.60 | 2.60 | 2.565 | 35,211 | |
| 2.58 | -0.005 | -0.2% | 2.605 | 2.645 | 2.575 | 14,962 | |
| 2.585 | -0.025 | -1.0% | 2.60 | 2.61 | 2.57 | 36,416 | |
| 2.61 | -0.015 | -0.6% | 2.61 | 2.615 | 2.58 | 44,780 | |
| 2.625 | -0.015 | -0.6% | 2.64 | 2.64 | 2.62 | 36,512 | |
| 2.64 | -0.01 | -0.4% | 2.645 | 2.665 | 2.635 | 23,476 | |
| 2.65 | -0.05 | -1.9% | 2.70 | 2.73 | 2.60 | 73,285 | |
| 2.70 | -0.055 | -2.0% | 2.75 | 2.75 | 2.70 | 20,697 | |
| 2.755 | -0.005 | -0.2% | 2.75 | 2.765 | 2.715 | 15,704 | |
| 2.76 | +0.04 | +1.5% | 2.74 | 2.78 | 2.72 | 102,995 | |
| 2.72 | 0.00 | 0.0% | 2.72 | 2.72 | 2.71 | 15,478 | |
| 2.72 | +0.01 | +0.4% | 2.71 | 2.765 | 2.71 | 18,458 | |
| 2.71 | -0.07 | -2.5% | 2.785 | 2.795 | 2.71 | 27,168 | |
| 2.78 | 0.00 | 0.0% | 2.76 | 2.79 | 2.70 | 31,621 | |
| 2.78 | -0.03 | -1.1% | 2.81 | 2.83 | 2.74 | 39,721 | |
| 2.81 | +0.015 | +0.5% | 2.825 | 2.83 | 2.74 | 41,167 | |
| 2.795 | +0.005 | +0.2% | 2.80 | 2.835 | 2.77 | 38,026 | |
| 2.79 | -0.03 | -1.1% | 2.825 | 2.825 | 2.78 | 53,688 | |
| 2.82 | +0.005 | +0.2% | 2.83 | 2.83 | 2.80 | 33,271 | |
| 2.815 | -0.005 | -0.2% | 2.835 | 2.84 | 2.795 | 41,857 | |
| 2.82 | 0.00 | 0.0% | 2.82 | 2.82 | 2.82 | 31,467 | |
| 2.82 | 0.00 | 0.0% | 2.82 | 2.82 | 2.82 | 62,065 | |
| 2.82 | 0.00 | 0.0% | 2.82 | 2.82 | 2.82 | 110,092 | |
| 2.82 | 0.00 | 0.0% | 2.82 | 2.82 | 2.82 | 26,022 | |
| 2.82 | 0.00 | 0.0% | 2.82 | 2.82 | 2.82 | 13,677 | |
| 2.82 | +0.005 | +0.2% | 2.815 | 2.83 | 2.76 | 28,784 | |
| 2.815 | -0.035 | -1.2% | 2.825 | 2.85 | 2.80 | 34,457 | |
| 2.85 | -0.03 | -1.0% | 2.895 | 2.895 | 2.83 | 29,112 | |
| 2.88 | +0.005 | +0.2% | 2.90 | 2.92 | 2.86 | 34,630 | |
| 2.875 | -0.015 | -0.5% | 2.89 | 2.925 | 2.85 | 27,831 | |
| 2.89 | +0.02 | +0.7% | 2.88 | 2.92 | 2.87 | 34,799 | |
| 2.87 | +0.03 | +1.1% | 2.825 | 2.88 | 2.80 | 32,047 | |
| 2.84 | -0.055 | -1.9% | 2.89 | 2.89 | 2.80 | 30,691 | |
| 2.895 | +0.025 | +0.9% | 2.90 | 2.925 | 2.825 | 35,477 | |
| 2.87 | -0.015 | -0.5% | 2.85 | 2.915 | 2.82 | 47,490 | |
| 2.885 | -0.01 | -0.3% | 2.895 | 2.92 | 2.85 | 8,474 | |
| 2.895 | +0.005 | +0.2% | 2.865 | 2.895 | 2.845 | 10,408 | |
| 2.89 | -0.005 | -0.2% | 2.90 | 2.90 | 2.84 | 39,768 | |
| 2.895 | +0.025 | +0.9% | 2.87 | 2.915 | 2.835 | 36,561 | |
| 2.87 | -0.06 | -2.0% | 2.90 | 2.925 | 2.855 | 26,801 | |
| 2.93 | -0.025 | -0.8% | 2.98 | 2.99 | 2.90 | 32,986 | |
| 2.955 | -0.035 | -1.2% | 3.02 | 3.03 | 2.93 | 21,630 | |
| 2.99 | -0.005 | -0.2% | 2.995 | 3.01 | 2.95 | 10,837 | |
| 2.995 | -0.025 | -0.8% | 3.02 | 3.02 | 2.97 | 31,266 | |
| 3.02 | +0.07 | +2.4% | 2.975 | 3.02 | 2.90 | 70,721 | |
| 2.95 | +0.015 | +0.5% | 2.935 | 2.975 | 2.92 | 22,178 | |
| 2.935 | -0.055 | -1.8% | 2.95 | 2.985 | 2.90 | 61,230 | |
| 2.99 | -0.035 | -1.2% | 3.03 | 3.04 | 2.985 | 30,674 | |
| 3.025 | -0.015 | -0.5% | 3.04 | 3.055 | 2.99 | 15,912 | |
| 3.04 | +0.02 | +0.7% | 3.00 | 3.07 | 3.00 | 17,456 | |
| 3.02 | 0.00 | 0.0% | 3.04 | 3.04 | 3.01 | 7,260 | |
| 3.02 | -0.01 | -0.3% | 3.03 | 3.065 | 3.00 | 28,707 | |
| 3.03 | -0.03 | -1.0% | 3.025 | 3.08 | 3.025 | 10,891 | |
| 3.06 | +0.02 | +0.7% | 3.095 | 3.10 | 3.025 | 29,248 | |
| 3.04 | +0.045 | +1.5% | 3.04 | 3.11 | 2.995 | 202,544 | |
| 2.995 | +0.12 | +4.2% | 2.875 | 3.01 | 2.875 | 96,823 | |
| 2.875 | +0.005 | +0.2% | 2.87 | 2.90 | 2.85 | 32,563 |
- Ticker
- Munich:6NQ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Jun 29, 2026
Synthaverse To End Distribution Agreement With Valentis In Turkey
Latest news
Synthaverse To End Distribution Agreement With Valentis In Turkey
Jun 29, 2026
Closed 3.00 (+13.0%) on Jun 29, 2026
Synthaverse Q1 Net Loss 3.6 Million Zlotys
May 28, 2026
Closed 2.92 (+0.2%) on May 28, 2026
Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador
May 27, 2026
Closed 2.91 (-0.7%) on May 27, 2026
Synthaverse Gets Marketing Authorization For Onko BCG In Serbia
May 15, 2026
Closed 3.08 (-1.3%) on May 15, 2026
Synthaverse Appoints Artur Chodkowski As CEO
Jan 14, 2026
Closed 4.09 (-1.7%) on Jan 14, 2026
Synthaverse Q3 Net Loss 7.7 Million Zlotys
Nov 28, 2025
Closed 3.90 (-3.3%) on Dec 1, 2025
SYNTHAVERSE Spolka Akcyjna on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 6 in the last 12 months · 9 in all · newest Jun 29, 2026 · oldest 2025
Where SYNTHAVERSE Spolka Akcyjna is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| GPW:SVE · Home listing | GPW | Poland | PLN |
| LSE:0RKM | LSE | United Kingdom | PLN |
| gettex:6NQ | gettex | Germany | EUR |
| Frankfurt:6NQ | Frankfurt | Germany | EUR |
| Lang & Schwarz:A1J10U | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1J10U | LS Exchange | Germany | EUR |
| Munich:6NQ · This page | Munich | Germany | EUR |
| Stuttgart:6NQ | Stuttgart | Germany | EUR |
Valuation
EV/sales 5.9× against a median of 28.6×: 2nd lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 288.2M PLN
- P/E
- Loss
- EV/sales
- 5.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.7×
- Gross margin
- 49.6%
- Operating margin
- −38.9%
- Net margin
- −43.1%
- Debt to equity
- 0.8×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| SYNTHAVERSE Spolka Akcyjna · GPW:SVE | US$48.68M | US$70.98M | n/a | 5.9× | n/a | 1.7× | −43.1% | 0.8× | n/a |
| Aldeyra Therapeutics, Inc. · NASDAQ:ALDX | US$50.70M | US$9.72M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 0.66 |
| Clene Inc. · NASDAQ:CLNN | US$50.69M | US$58.31M | n/a | 245× | n/a | n/a | n/a | n/a | 1.48 |
| Aptamer Sciences, Inc. · KRX:291650 | US$49.50M | US$34.66M | n/a | 8.6× | n/a | 1.6× | −215.8% | 0.0× | n/a |
| Acrivon Therapeutics, Inc. · NASDAQ:ACRV | US$49.35M | −US$26.60M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.09 |
| Heron Therapeutics, Inc. · NASDAQ:HRTX | US$48.04M | US$156.3M | n/a | 1.1× | n/a | 9.8× | −14.5% | 26.8× | 1.93 |
| Helix BioPharma Corp. · TSX:HBP | US$47.94M | US$50.27M | n/a | n/a | n/a | 4.8× | n/a | 0.3× | 0.36 |
| Oncolytics Biotech Inc. · NASDAQ:ONCY | US$47.66M | US$45.23M | n/a | n/a | n/a | n/a | n/a | n/a | 1.27 |
| THX Pharma · EURONEXT:ALTHX | US$47.23M | US$30.92M | n/a | n/a | n/a | 14.5× | n/a | 0.9× | n/a |
| FluoGuide A/S · OMXSTO:FLUO | US$47.17M | US$43.89M | n/a | 5,538× | n/a | 10.5× | n/a | 0.9× | n/a |
| Rafael Holdings, Inc. · NYSE:RFL | US$47.10M | US$25.00M | n/a | 28.6× | n/a | 0.7× | n/a | 0.0× | 0.92 |
| Median of the others | US$47.99M | US$39.28M | 28.6× | 3.2× | −115.2% | 0.2× | 1.27 |
Team and board
Officers
| Officer | Role |
|---|---|
| Artur Chodkowski | CEO |
| Wiktor Napióra | Vice-President |
| Jakub Winkler | Board Member, CLO |
Board
| Director | Role |
|---|---|
| Jarosław Paweł Błaszczak | Chairman |
| Dirk Pamperin | Member of the Supervisory Board |
| Jakub Winkler | Board Member, CLO |
| Konrad Miterski | Member of the Supervisory Board |
| Maciej Korniluk | Member of the Supervisory Board |
| Maciej Siedlar | Member of the Supervisory Board |
| Piotr Kwaśniewski | Member of the Supervisory Board |
| Waldemar Sierocki | Member of the Supervisory Board |
| Wiktor Napióra | Vice-President |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Sep 2, 2026 | −3.0% |
| Q1 2026 | Jun 3, 2026 | −3.5% |
| Q4 2025 | Feb 25, 2026 | +0.8% |
| Q3 2025 | Dec 3, 2025 | −3.8% |
| Q2 2025 | Sep 3, 2025 | −1.7% |
| Q1 2025 | May 29, 2025 · Before open | −6.1% |
| Q4 2024 | Feb 26, 2025 | −0.3% |
| Q3 2024 | Nov 20, 2024 · Before open | +1.4% |
| Q2 2024 | Aug 28, 2024 | +0.2% |
| Q1 2024 | May 22, 2024 · After close | −0.4% |
All 16 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Feb 28, 2024 | −2.1% |
| Q3 2023 | Nov 22, 2023 · After close | −2.0% |
| Q2 2023 | Sep 21, 2023 | −1.7% |
| Q1 2023 | May 31, 2023 | −2.8% |
| Q4 2022 | Mar 1, 2023 | −0.5% |
| Q3 2022 | Nov 30, 2022 | −11.0% |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.0M | 71.8M | 58.6M | 50.4M | 41.2M | 40.2M | 39.1M | 32.3M | 31.4M | 36.3M |
| Cost of revenue | 29.0M | 27.5M | 23.4M | 22.4M | 18.5M | 19.6M | 17.9M | 16.1M | 17.4M | 23.0M |
| Gross profit | 13.0M | 44.3M | 35.2M | 28.5M | 22.7M | 20.6M | 21.3M | 16.2M | 14.0M | 13.3M |
| Research and development | 6.00K | 15.0K | 2.42M | 2.10M | ||||||
| Selling, general and administrative | 31.0M | 24.8M | 18.2M | 12.7M | 12.3M | 13.9M | 11.4M | 11.9M | 12.9M | 11.8M |
| Operating income | -20.6M | 12.4M | 8.65M | 9.84M | 7.19M | 5.93M | 5.72M | -35.4M | 4.85M | -27.8M |
| Depreciation and amortization | 13.3M | 8.09M | 6.63M | 6.22M | 6.54M | 5.83M | 5.83M | 6.07M | 6.34M | 3.92M |
| EBITDA | -7.28M | 20.5M | 15.3M | 16.1M | 13.7M | 11.8M | 11.6M | -29.4M | 11.2M | -23.9M |
| Interest expense | 3.95M | 3.10M | 1.69M | 836.0K | 1.28M | 1.65M | 2.02M | 2.66M | 3.96M | 3.69M |
| Income before tax | -23.9M | 9.64M | 6.57M | 8.35M | 5.89M | 4.31M | 3.72M | -38.2M | 1.68M | -30.8M |
| Income tax | -3.98M | 2.09M | 1.81M | 2.27M | 1.64M | -126.0K | 1.24M | -5.81M | 1.09M | -7.31M |
| Net income | -19.9M | 7.55M | 4.76M | 6.08M | 4.25M | 4.44M | 2.48M | -32.4M | 588.0K | -23.5M |
| Earnings per share, basic | -0.27 | 0.11 | 0.07 | 0.09 | 0.07 | 0.07 | 0.04 | -0.54 | 0.01 | -0.53 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.67M | 760.0K | 2.17M | 27.1M | 14.3M | 1.84M | 660.0K | 58.0K | 2.32M | 672.0K |
| Short-term investments | 56.0K | 5.17M | -147.0K | 5.68M | ||||||
| Receivables | 22.7M | 35.7M | 20.3M | 15.1M | 11.6M | 10.5M | 4.83M | 6.51M | 8.16M | |
| Inventory | 12.3M | 9.72M | 15.5M | 12.7M | 9.32M | 9.10M | 8.63M | 6.94M | 9.32M | 10.7M |
| Current assets | 121.9M | 46.2M | 45.6M | 55.4M | 40.8M | 22.0M | 14.8M | 14.3M | 21.8M | 25.5M |
| Goodwill | 0 | 0 | 0 | |||||||
| Total assets | 304.1M | 298.6M | 265.9M | 163.1M | 116.8M | 85.9M | 81.1M | 86.3M | 121.0M | 112.7M |
| Accounts payable | 2.17M | 16.9M | 2.88M | 2.78M | 1.77M | 2.29M | 3.30M | 2.75M | 2.69M | 3.63M |
| Current liabilities | 135.0M | 43.0M | 31.0M | 24.5M | 17.2M | 24.6M | 20.3M | 22.3M | 26.0M | 68.8M |
| Long-term debt | 58.2M | 58.9M | 5.98M | 1.79M | ||||||
| Total debt | 84.6M | 80.4M | 70.0M | 15.1M | 6.49M | 13.3M | 9.57M | 12.7M | 13.9M | 63.3M |
| Total liabilities | 139.4M | 177.2M | 153.3M | 57.5M | 42.3M | 48.6M | 48.2M | 55.9M | 63.2M | 111.5M |
| Shareholders' equity | 124.7M | 121.5M | 112.6M | 105.6M | 74.6M | 37.3M | 32.9M | 30.4M | 57.8M | 1.13M |
| Shares outstanding | 72.6M | 70.5M | 70.3M | 65.4M | 63.1M | 62.3M | 62.3M | 60.6M | 57.5M | 44.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 7.22M | 13.7M | -5.34M | 2.95M | -3.28M | 343.0K | 8.16M | -620.0K | 4.36M | 15.8M |
| Capital spending | -28.0M | -41.8M | -112.6M | -36.8M | -18.4M | -2.02M | -806.0K | -2.64M | -484.0K | -5.01M |
| Free cash flow | -20.8M | -28.1M | -117.9M | -33.8M | -21.7M | -1.68M | 7.35M | -3.26M | 3.87M | 10.8M |
| Cash from investing | -27.8M | -25.9M | -72.9M | -27.0M | -4.49M | -2.02M | -690.0K | -2.64M | 5.34M | -4.77M |
| Cash from financing | 21.5M | 10.7M | 53.3M | 36.8M | 20.2M | 2.86M | -6.87M | 1.00M | -8.05M | -10.4M |
| Dividends paid | -2.22M | |||||||||
| Change in cash | 913.0K | -1.42M | -24.9M | 12.8M | 12.5M | 1.18M | 602.0K | -2.26M | 1.65M | 619.0K |
Cap table
Built by 6ix from SYNTHAVERSE Spolka Akcyjna’s releases
- Common shares
- 76,019,403
- Fully diluted
- 76,019,403
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 76,019,403 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 76,019,403 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Artur Chodkowski | CEO · Since at least Jan 14, 2026 |
| Dirk Pamperin | Member of the Supervisory Board · Since at least Nov 5, 2026 |
| Jakub Winkler | Board Member, CLO · Since at least Nov 5, 2026 |
| Jarosław Paweł Błaszczak | Chairman · Since at least Nov 5, 2026 |
| Konrad Miterski | Member of the Supervisory Board · Since at least Nov 5, 2026 |
| Maciej Korniluk | Member of the Supervisory Board · Since at least Nov 5, 2026 |
| Maciej Siedlar | Member of the Supervisory Board · Since at least Nov 5, 2026 |
| Piotr Kwaśniewski | Member of the Supervisory Board · Since at least Nov 5, 2026 |
| Waldemar Sierocki | Member of the Supervisory Board · Since at least Nov 5, 2026 |
| Wiktor Napióra | Vice-President · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about SYNTHAVERSE Spolka Akcyjna.